Gadobutrol Injection

It is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. It is used in the treatment of acute lymphoblastic leukemia.

Strength: 5ml:3750IU; 2ml:1500IU

It has...

It is used for the treatment of advanced gastric cancer.

Strength: 

Tegafur: 20mg, Gimeracil: 5.8mg, Oteracil potassium: 19.6mg;

Tegafur: 25mg, Gimeracil: 7.25mg, Oteracil potassium: 24.5mg

It has been approved by NMPA.

It is an oral chemotherapy drug. It is analkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.

Strength: 100mg

It has been approved by CFDA.

It is a bisphosphonate drug given intravenously to treat some bone diseases. It is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis....

It is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, andepidural and caudal blocks. It is sometimes used in combination with epinephrine to prevent systemic absorption and extend the duration of action.

Strength: 133mg/10ml...

Eribulin Mesylate Injection is used to treat certain patients with breast cancer and liposarcoma.

Strength: 1mg/2ml

This product is still in R & D stage.

This is a kind of contrast media. 
Strength:  (529mg/ml) *5ml  *10ml  *15ml  *20ml

It is still in R&D stage.

Iohexol is a kind of contrast media.

Strength: to be determined.

This product is still in R&D stage.

Ioversol is an organoiodine compound that used as a contrast medium. It features both a high iodine content, as well as several hydrophilic groups.

Strength: 320mg I/ml (50ml; 100ml)

Dossiers are in preparation for US-FDA approval.

Azilsartan is an angiotensin II receptor antagonist indicated for the treatment of mild to moderate essential hypertension. Strength: 20mg, 40mg
Standard: In-house

It is a kind of analgesics.

Strength: 4mg/2ml, 1mg/1ml


Standard: In-house

Dutasteride is a triple 5α-reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone. It is used to treat benign prostatic hyperplasia. It increases the risk of erectile dysfunction and decreased sexual desire.

Strength: 0.5mg


Standard: In-house

Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.